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htcense.Abstract Objective: To evaluate the usefulness of intra-operative ultrasonography (US) for local-
ization of nonpalpable breast cancer that could be visualized with preoperative US.
Patients and methods: We prospectively assessed 57 nonpalpable sonographically detected and
biopsy-proved breast cancers in 57 patients. US localization of breast cancers was performed in
the OR by the radiologist immediately before deﬁnitive surgery using either injection of blue dye
or placement of a guide wire after marking of the skin overlying the lesion with a marking pen.
Tumor identiﬁcation, the correlation with tumor diameter on preoperative US, analysis of resection
margins, and the need to perform surgical re-excision were analyzed.
Results: US correctly localized all lesions at surgery. Re-excision due to positive resection margins
was necessary in four patients (7%) including three patients with ductal carcinoma-in situ (DCIS)
and one patient with invasive disease at the surgical margin. Mastectomy was necessary in one
patient (1.7%) due to multifocal invasive carcinoma. Thus, the re-excision rate was 8.7% (5 of 57).
Conclusion: US in the operating room is an attractive alternative guiding tool of localizing
nonpalpable breast cancers that have been seen on preoperative US improving the process of
image-guided surgery.
 2013 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
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The widespread use of screening mammography has delivered
increased numbers of nonpalpable breast cancers to the breast
surgeon and the use of needle biopsy delivers the preoperative
diagnosis of breast cancer of most nonpalpable lesions, which
results in more-efﬁcient ﬁrst surgical procedures (1,2). Therapy
of these early breast cancers requires accurate and complete
excision of these small primary lesions. Image guidance is nec-Production and hosting by Elsevier B.V.
3.01.007
Fig. 1 Preoperative US of breast cancer. M: inﬁltrating ductal
carcinoma of the left breast (arrows) characterized as hypoechoic
heterogenous lesion with angulated margins and the lesion shows
posterior shadowing.
Fig. 2 Markings drawn on the skin of the breast overlying the
lesion in the OR immediately before surgery. The surgical incision
and planned volume of the breast tissue, skin, and fascia-pectoralis
muscle to be removed were drawn on the skin of this patient’s
breast. The central drawn circle identiﬁes the underlying US
location of the tumor; the continuous line outlines the ellipse of
the skin to be resected; and the interrupted circumferential line
deﬁnes the volume of the breast tissue to be excised.
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tumors. The standard method of image guidance has been wire
localization with mammography to visualize the lesion (3).
This requires an imaging procedure in radiology and then tra-
vel to the operating room (OR). This process presents a variety
of inefﬁciencies that may occur between those two sites. By the
time the patients arrive on the operating table, the localizing
wire may have been moved or displaced, impairing the accu-
racy of the surgical procedure. In addition, scheduling patients
both in radiology and then in surgery may be difﬁcult. Another
disadvantage of the wire placement is that the patient has to
undergo an extra intervention before surgery. Wire placement
is an unpleasant procedure and heightens the patient’s anxiety
related to the surgical intervention (2).
It is, therefore, not surprising that alternative methods for
tumor localization, such as US have been investigated. Recent
studies found that intra-operative sonography can be a reliable
and helpful tool in OR, not only for tumor localization of non-
palpable breast cancers, but also for orientation during tumor
excision (2,4).
Accordingly, we designed our study to evaluate the useful-
ness of intra-operative US for the localization of nonpalpable
breast cancer.
2. Patients and methods
This prospective study was conducted from June 2009 to Au-
gust 2012 for 57 patients with 57 nonpalpable sonographically
detected and biopsy-proved breast cancers who underwent
intraoperative US-guided localization for the breast cancers
in the OR before deﬁnitive surgery. The age range was 39–
83 years, with 45% between the ages of 50 and 69 years and
22% younger than 50 years.
All patients underwent focused breast US of the area of
interest in the radiology department by an experienced radiol-
ogist prior to surgery using a high-resolution 5–9 MHz linear
array transducer of (Medison SONOACE 6000 C unit). Breast
US provided speciﬁc information regarding the tumor location
and extent, the tumor depth from the skin and distance from
pectoralis muscle, the presence of ductal extension, and the
presence of multifocal or satellite lesions (Fig. 1).
The US-guided localization procedure was explained to the
patient in detail. After informed consent had been obtained,
patients were assigned to the surgical treatment.
The patient was brought to the OR, given sedation, and
examined with US by the same radiologist and the same US
machine used in pre-operative assessment in the radiology
department which was brought into the OR for each of the
57 patients. Once the lesion is identiﬁed, direct comparison
was made between what was seen in the OR and what the le-
sion looked like in the previous preoperative US picture.
Before US-guided localization, the skin overlying the lesion
was marked with a marking pen to further orient the surgeon.
The surgical incision and planned volume of the breast tissue,
skin, and fascia-pectoralis muscle to be removed were drawn
on the skin of the breast (Fig. 2).
Intraoperative US-guided localization was performed by
the radiologist using either blue dye injection (n= 43) or
guide-wire placement (n= 14). When blue dye was used, a
very small amount (1 ml) of methylene blue dye was injected
around the lesion just before the surgical preparation of thepatient. The dye was placed on four sides of the lesion. The last
location blue dye was placed just below the skin, in the US
window between the transducer and the lesion to help ﬁnd
the general location of the lesion (Fig. 3). After the blue dye
is found at surgery, a wide excision is accomplished without
further use of the US transducer. When using a guide wire (Vi-
vant Medical, Inc., Palo Alto, CA), it was placed by using US
guidance to one side of the lesion according to the surgeon’s
preference (n= 8) or more than one guide wire can be placed
to bracket the lesion (n= 6).
All US-guided resected specimens were checked with US in
the OR and the US probe used was held in a sterile plastic
sheath (Fig. 4). Besides documenting that the lesion was re-
moved, the specimen US was a guide for further resection of
visibly close margins.
In addition to standard pathologic information, margins
were carefully identiﬁed, inked, and examined. The pathologic
status of the margins from the initial surgical excision speci-
Fig. 3 The lesion during surgical excision identiﬁed by the
injected blue dye.
Fig. 4 In the operating room, the surgical specimen is checked
with US for adequate margins.
Table 1 Patient and tumor characteristics.
Characteristic Value and percentage
No. patients 57
Age, mean (range) (y) 39–83
Breast-conserving therapy 57
Tumor diameter, mean (SD) (cm) 0.7–2.6 cm, 1.2 ± 0.5
Accurate localization of breast cancer 57 (100%)
Margins for invasive carcinoma
Satisfactory 53 (93%)
Unsatisfactory 4 (7%)
Surgical re-excision for carcinoma 5 (8.7%)
Positive resection margin 4 (7%)
Multifocal invasive cancer (mastectomy) 1 (1.7%)
Tumor type on US examination
Ductal carcinoma-in situ (DCIS) 2 (3.5%)
Invasive carcinoma 55 (96.5%)
Tumor type on pathological examination
Ductal carcinoma-in situ (DCIS) 12 (21%)
Invasive carcinoma 45 (79%)
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later procedures, was recorded. The distance from the tumor
to the closest margin of excision was also determined. Resec-
tions were described as being inadequate when microscopic tu-
mor involvement of the (inked) resection border was present.
A microscopically adequate margin was deﬁned as P10 mm
(4).
The mean follow-up was 25 months (range, 8–38 months).
The patients underwent physical examination and mammo-
gram of the affected breast every 6 months for the ﬁrst 2 years.
Thereafter, the same examinations occurred every year.
3. Results
US localization in the OR took very little time (10–20 min).
The correlation with preoperative diagnostic US for tumor
dimensions was satisfactory. The sizes of the masses measured
on the US ranged from 0.7 to 2.6 cm (mean ± SD,
1.2 ± 0.5 cm).
Sonography of the freshly excised specimen in the OR
showed the absence of the lesion in the specimen in two cases
prompted immediate re-excision which was successful. Thus,
US localization correctly identiﬁed all target lesions at the ini-
tial surgery and breast cancer was found in each case of US
localization on the initial specimen (100% accuracy).
Re-excision due to positive resection margins was necessary
in four patients (7%) including three patients with ductal car-
cinoma-in situ (DCIS) and one with invasive disease at the sur-
gical margin. In addition, mastectomy was necessary in one
patient (1.7%) due to multifocal invasive carcinoma unknownat the time of US-guided excision. Thus, ﬁve patients required
surgical re-excision and the re-excision rate for all US-guided
procedures was 8.7% (5 of 57).
On pathologic examination, there were 12 patients (21%)
with DCIS and the remaining 45 patients (79%) all had inva-
sive disease. US identiﬁed only two patients with DCIS (2 of
57; 3.5%); the remaining 55 patients (96.5%) all had invasive
disease. Thus, DCIS could not be visible by US in 10 patients
(10 of 57; 17.5%) and ﬁve of these in situ lesions had promi-
nent calciﬁcations (calciﬁed DCIS). Patient and tumor charac-
teristics are listed in Table 1.
4. Discussion
There are a variety of techniques to localize breast cancer with
US in the OR. Some techniques involve continuous use of the
US transducer during the operation (5). Others use the US to
inject blue dye or to place a guide wire or other marking device
to guide the procedure. This is most similar to the standard
mammographic localization (2,4). Still others simply use US
to mark the skin overlying the lesion; thereafter they operate
at the marked site (6). This gives only a skin surface orienta-
tion, which may shift in the patient with pendulous breasts.
In our study, we used two methods to localize breast cancer
with US in the OR: injection of blue dye or placement of a
guide wire around the lesion. However, before US-guided
localization by either method, we used US in OR to mark
the skin overlying the lesion with a marking pen to further ori-
ent the surgeon. The surgical incision and planned volume of
the breast tissue, skin, and fascia-pectoralis muscle to be re-
moved were drawn on the skin of the breast (Fig. 2). When
using blue dye injection, a marking pen can identify where
the blue dye is located within the breast. This is most impor-
tant with pendulous or large breasts.
The advantage of using blue dye is that it is readily avail-
able (for the sentinel node procedure). A small amount of
dye is placed around the lesion, making it very visible. The dis-
advantage of blue dye is that there is no guide wire to see or
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geon’s orientation. One potential problem occurs when too
much dye (more than 1 ml) is placed in any one area so that
the blue dye spreads within the breast and can make localiza-
tion more difﬁcult (2). In spite of these limitations of using
blue dye, most patients in our study underwent US localization
using blue dye (no = 43) and we found that US localization
correctly identiﬁed all target lesions at the initial surgery. This
conforms to Cary et al., (2). The goal of intraoperative US
localization is to accurately identify the lesion and facilitate
surgical excision with a clear margin. Tumors resected with in-
volved margins have an increase in the local recurrence rate,
thus re-excision for positive margins is indicated (7). In our
study, re-excisions were required for positive margins for only
four patients (7%) and mastectomy was necessary in one pa-
tient (1.7%). Thus, ﬁve patients required surgical re-excision
and the re-excision rate for all US-guided procedures was
8.7% (5 of 57) which is comparable to other series of US local-
ization (5,8–10).
The pathologic ﬁndings in the ﬁve patients required re-exci-
sions in our study included calciﬁed DCIS in two patients,
noncalciﬁed DCIS in one patient, invasive disease at the surgi-
cal margin in one patient (these patients underwent re-exci-
sion) and multifocal invasive carcinoma in one patient
(underwent mastectomy). Thus, DCIS was the pathologic ﬁnd-
ings in the three of the ﬁve patients required re-excisions and
multifocal invasive carcinoma in one patient. This conforms
to Cary et al. (2) who found that regardless of the type of imag-
ing guidance, patients with DCIS and multifocal invasive can-
cer will be at increased risk for a positive margin and at
increased risk for re-excision or mastectomy. These ﬁndings
were not predictable before surgery by US. This may be ex-
plained by ability of US to detect invasive carcinoma more
than DCIS particularly the calciﬁed type because calciﬁcations
are not seen with US and the ductal process extends beyond
the imaged invasive lesion (2). Therefore, whenever the preop-
erative needle biopsy shows DCIS, a wider excision might be
planned. In addition, the vast majority of breast cancers is uni-
focal and, if visible with US, will beneﬁt from the improved
efﬁciency of US guidance.
One could theorize that real-time imaging with US during
the operation allows for a more accurate determination of a
margin around the tumor and that, therefore, specimen size
will be smaller. This is important not only for the success rate
of the procedure, but also for cosmetic outcome in breast-con-
serving treatment (11). Frans et al., (4) haveconﬁrmed this
hypothesis. However, to achieve these objectives in our study
we checked all US-guided resected specimens with US in the
OR and showed the absence of the lesion in the specimen in
two cases prompted immediate re-excision which was success-
ful. Besides documenting that the lesion was removed, the
specimen US was able to delineate a margin around a nonpal-
pable breast cancer, which made adequate resection possible
without the unnecessary sacriﬁce of the healthy breast tissue.
Thus sonography of the specimen can indicate within seconds
whether the excision has been successful.
One ‘‘US pearl’’ is that US makes a breast lesion appear
closer to the skin than is actually found at surgery. While
the lesion is visualized with US, there is direct pressure on
the subcutaneous tissue and breast, essentially compressing
the distance from the skin to the lesion. Then, during surgical
exposure of the lesion, the skin is retracted up and away fromthe lesion. This magniﬁes the operative distance from the skin
to the lesion, making the surgical distance to the lesion greater
than expected.
There are several beneﬁts of intraoperative US localization.
The most advantageous point is that it improves surgical
scheduling without losing accuracy. The patient arrives to
the OR calm and relaxed and patients do not have to arrive
4 h before their operation. The surgeon has complete control
of the timing of surgery. Far longer than 30 min of OR time
is added to give the time needed for localization. Often, as in
our study the localization is completed within 10 min because
we made direct comparison between the preoperative and
intraoperative US pictures for the lesion. In addition, patients
ﬁnd it more comfortable to avoid a needle procedure just be-
fore their surgery. No repeat wire readjustments, no dislodged
wires, and no vasovagal episodes occur for the patient. Finan-
cially, there are no charges for the radiology localization room
or several ﬁlms. Charges are generated by the radiologist who
localizes the lesion and for the US use. Overall, it saves surgical
time, patient inconvenience, and money. Therefore, the sur-
geon, the patient, and the OR staff all appreciate the efﬁciency
of US localization.
5. Conclusion
US proved to be a reliable and a very useful tool to localize
non-palpable breast cancer in the OR, improving the process
of image-guided surgery. US localization is accurate, time efﬁ-
cient, and technically feasible. It simpliﬁes organizational work
and spares the patients’ discomfort of preoperative needle
localization. Therefore, intraoperative US localization should
be considered whenever a breast cancer requires image-guided
excision.
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